Gilead Sciences, Inc.
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences Unrecognized tax benefits that, if recognized, would by Year
Unrecognized tax benefits that, if recognized, would affect the effective tax rate ($M) ($M)
Gilead Sciences Unrecognized tax benefits that, if recognized, would: $900M in FY2025, down 35.7% from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-24) ↗
Reported in Form 10-K Note 15.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Unrecognized tax benefits that, if recognized, would affect the effective tax rate ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 900 | -35.7% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 1,400 | +50.7% | Form 10-K (filed 2026-02-24) ↗ |
| FY2023 | Dec 31, 2023 | 929 | -1.8% | Form 10-K (filed 2025-02-28) ↗ |
| FY2022 | Dec 31, 2022 | 946 | +18.3% | Form 10-K (filed 2024-02-23) ↗ |
| FY2021 | Dec 31, 2021 | 800 | -33.3% | Form 10-K (filed 2023-02-22) ↗ |
| FY2020 | Dec 31, 2020 | 1,200 | -25.0% | Form 10-K (filed 2022-02-23) ↗ |
| FY2019 | Dec 31, 2019 | 1,600 | +23.1% | Form 10-K (filed 2021-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 1,300 | -27.8% | Form 10-K (filed 2019-02-26) ↗ |
| FY2017 | Dec 31, 2017 | 1,800 | 0.0% | Form 10-K (filed 2019-02-26) ↗ |
| FY2016 | Dec 31, 2016 | 1,800 | +38.5% | Form 10-K (filed 2018-02-27) ↗ |
| FY2015 | Dec 31, 2015 | 1,300 | +115.9% | Form 10-K (filed 2017-02-27) ↗ |
| FY2014 | Dec 31, 2014 | 602 | – | Form 10-K (filed 2016-02-24) ↗ |
Cite this data
StockData. (2026). Gilead Sciences Unrecognized tax benefits that, if recognized, would ($M), annual FY2014–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/utb-etr-impact
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.